Notice of Change to Key Dates in PAR-19-259, "NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)"

Notice Number: NOT-DA-20-050

Key Dates
Release Date: April 15, 2020

Related Announcements
PAR-19-259

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-19-259 "NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)".

Current Language

Part 1. Overview

Key Dates:

Application Due Date(s)

September 25, 2019; September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

January 7, 2020; January 7, 2021; January 7, 2022 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

March 2020, March 2021, March 2022

Advisory Council Review

May 2020, May 2021, May 2022

Earliest Start Date

July 2020, July 2021, July 2022

Expiration Date

January 8, 2022

New Language

Part 1. Overview

Key Dates:

Application Due Date(s)

September 25, 2020; September 25, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

November 17, 2020 and November 17, 2021 by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

March 2021, March 2022

Advisory Council Review

May 2021, May 2022

Earliest Start Date

July 2021, July 2022

Expiration Date

November 18, 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kevin Walton, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0762
Email: kevin.walton@nih.gov

Meyer D. Glantz, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: mglantz@nida.nih.gov

Roger Little, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1316
Email: Roger.Little@nih.gov

Steven Grant, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-4877
Email: sgrant@nida.nih.gov